Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.

Article Details

Citation
Copy to clipboard

Ray LA, Chin PF, Miotto K

Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.

CNS Neurol Disord Drug Targets. 2010 Mar;9(1):13-22.

PubMed ID
20201811 [ View in PubMed
]
Abstract

Naltrexone is an opioid receptor antagonist with established efficacy, albeit moderate, for the treatment of alcohol dependence. This manuscript provides a critical review of the literature on naltrexone as a pharmacotherapy for alcoholism by covering the following areas: (a) clinical findings from treatment studies; (b) pharmacokinetics and safety data; (c) medication compliance and persistence; and (d) neurobiological and biobehavioral mechanisms of action of naltrexone for the indication of alcohol dependence. This review will then focus on the emerging literature on naltrexone pharmacogenetics, which has the potential to identify responders on the basis of genetic variation and to use genetic tools to individualize the use of this medication. Limitations and future directions in the research and practice of naltrexone for alcoholism are also outlined.

DrugBank Data that Cites this Article

Drugs